Veru Reports Third Quarter Fiscal 2022 Financial Results; Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Veru Reports Third Quarter Fiscal 2022 Financial Results; Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories

Veru, Inc. (VERU) Misses Q2 EPS by 12c, Misses on Revenue

August 11, 2022 6:31 AM EDT

Veru, Inc. (NASDAQ: VERU) reported Q2 EPS of ($0.28), $0.12 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $9.6 million versus the consensus estimate of $16.67 million.

For earnings history and earnings-related data on Veru, Inc. (VERU) click here.

... More